NYSE: CVSCvs Health Revenue
Cvs Health revenue was $394.08B for the trailing 12 months ending Sep 30, 2025, with -89.9% growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $102.9B, up 4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CVS annual revenue was $372.8B, with 4.2% growth year-over-year.
CVS past revenue growth
How has CVS's revenue growth performed historically?
Company
6.82%
Industry
11.19%
Market
20.46%
CVS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CVS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CVS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
CVS revenue history
Current Revenue
$394.1B
Current Earnings
$469.0M
Current Profit Margin
0.1%
CVS's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when CVS announces revenue.
CVS Revenue History By Year
| CVS Yearly Revenue | CVS Revenue | CVS Change | CVS Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $372.81B | $15.03B | +4.20% |
| 2023-12-31 | $357.78B | $35.31B | +10.95% |
| 2022-12-31 | $322.47B | $30.36B | +10.39% |
| 2021-12-31 | $292.11B | $23.41B | +8.71% |
| 2020-12-31 | $268.71B | $11.93B | +4.65% |
| 2019-12-31 | $256.78B | $62.20B | +31.96% |
| 2018-12-31 | $194.58B | $9.79B | +5.30% |
| 2017-12-31 | $184.79B | $7.24B | +4.08% |
| 2016-12-31 | $177.55B | $24.26B | +15.82% |
| 2015-12-31 | $153.29B | $13.92B | +9.99% |
| 2014-12-31 | $139.37B | $12.61B | +9.94% |
| 2013-12-31 | $126.76B | $3.64B | +2.96% |
| 2012-12-31 | $123.12B | $16.04B | +14.98% |
| 2011-12-31 | $107.08B | $11.30B | +11.80% |
| 2010-12-31 | $95.78B | -$2.44B | -2.48% |
| 2009-12-31 | $98.22B | $10.74B | +12.28% |
| 2008-12-31 | $87.47B | $11.14B | +14.60% |
| 2007-12-29 | $76.33B | $32.51B | +74.18% |
| 2006-12-30 | $43.82B | $6.81B | +18.41% |
| 2005-12-31 | $37.01B | $6.41B | +20.96% |
| 2005-01-01 | $30.59B | $4.01B | +15.07% |
| 2004-01-03 | $26.59B | $2.41B | +9.95% |
| 2002-12-28 | $24.18B | $1.94B | +8.72% |
| 2001-12-29 | $22.24B | $2.15B | +10.72% |
| 2000-12-30 | $20.09B | $1.99B | +10.99% |
| 2000-01-01 | $18.10B | $2.82B | +18.49% |
| 1998-12-31 | $15.27B | $1.52B | +11.08% |
| 1997-12-31 | $13.75B | $1.92B | +16.21% |
| 1996-12-31 | $11.83B | $2.07B | +21.18% |
| 1995-12-31 | $9.76B | $5.43B | +125.48% |
| 1994-12-31 | $4.33B | -$4.39B | -50.36% |
| 1993-12-31 | $8.72B | -$1.71B | -16.40% |
| 1992-12-31 | $10.43B | $546.66M | +5.53% |
| 1991-12-31 | $9.89B | N/A | N/A |
Cvs Health Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.